These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 16126231

  • 1. Molecular modeling of blood-brain barrier nutrient transporters: in silico basis for evaluation of potential drug delivery to the central nervous system.
    Allen DD, Geldenhuys WJ.
    Life Sci; 2006 Feb 02; 78(10):1029-33. PubMed ID: 16126231
    [Abstract] [Full Text] [Related]

  • 2. 3D-QSAR study of bis-azaaromatic quaternary ammonium analogs at the blood-brain barrier choline transporter.
    Geldenhuys WJ, Lockman PR, Nguyen TH, Van der Schyf CJ, Crooks PA, Dwoskin LP, Allen DD.
    Bioorg Med Chem; 2005 Jul 01; 13(13):4253-61. PubMed ID: 15878282
    [Abstract] [Full Text] [Related]

  • 3. Molecular modeling studies on the active binding site of the blood-brain barrier choline transporter.
    Geldenhuys WJ, Lockman PR, McAfee JH, Fitzpatrick KT, Van der Schyf CJ, Allen DD.
    Bioorg Med Chem Lett; 2004 Jun 21; 14(12):3085-92. PubMed ID: 15149650
    [Abstract] [Full Text] [Related]

  • 4. Brain drug targeting: a computational approach for overcoming blood-brain barrier.
    Mehdipour AR, Hamidi M.
    Drug Discov Today; 2009 Nov 21; 14(21-22):1030-6. PubMed ID: 19647097
    [Abstract] [Full Text] [Related]

  • 5. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
    Löscher W, Potschka H.
    Prog Neurobiol; 2005 May 21; 76(1):22-76. PubMed ID: 16011870
    [Abstract] [Full Text] [Related]

  • 6. Blood-brain barrier genomics and the use of endogenous transporters to cause drug penetration into the brain.
    Pardridge WM.
    Curr Opin Drug Discov Devel; 2003 Sep 21; 6(5):683-91. PubMed ID: 14579518
    [Abstract] [Full Text] [Related]

  • 7. Carrier-mediated delivery of metabotrophic glutamate receptor ligands to the central nervous system: structural tolerance and potential of the L-system amino acid transporter at the blood-brain barrier.
    Reichel A, Begley DJ, Abbott NJ.
    J Cereb Blood Flow Metab; 2000 Jan 21; 20(1):168-74. PubMed ID: 10616805
    [Abstract] [Full Text] [Related]

  • 8. Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations.
    Lee G, Dallas S, Hong M, Bendayan R.
    Pharmacol Rev; 2001 Dec 21; 53(4):569-96. PubMed ID: 11734619
    [Abstract] [Full Text] [Related]

  • 9. Macromolecular drug transport into the brain using targeted therapy.
    Lichota J, Skjørringe T, Thomsen LB, Moos T.
    J Neurochem; 2010 Apr 21; 113(1):1-13. PubMed ID: 20015155
    [Abstract] [Full Text] [Related]

  • 10. Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?
    Garcia-Garcia E, Andrieux K, Gil S, Couvreur P.
    Int J Pharm; 2005 Jul 25; 298(2):274-92. PubMed ID: 15896933
    [Abstract] [Full Text] [Related]

  • 11. 2B-Trans technology: targeted drug delivery across the blood-brain barrier.
    Gaillard PJ, de Boer AG.
    Methods Mol Biol; 2008 Jul 25; 437():161-75. PubMed ID: 18369968
    [Abstract] [Full Text] [Related]

  • 12. 3D QSAR investigation of the blood-brain barrier penetration of chemical compounds.
    Lessigiarska I, Pajeva I, Cronin MT, Worth AP.
    SAR QSAR Environ Res; 2005 Jul 25; 16(1-2):79-91. PubMed ID: 15844444
    [Abstract] [Full Text] [Related]

  • 13. Drug delivery and in vitro models of the blood-brain barrier.
    Cucullo L, Aumayr B, Rapp E, Janigro D.
    Curr Opin Drug Discov Devel; 2005 Jan 25; 8(1):89-99. PubMed ID: 15679176
    [Abstract] [Full Text] [Related]

  • 14. Constructing optimum blood brain barrier QSAR models using a combination of 4D-molecular similarity measures and cluster analysis.
    Pan D, Iyer M, Liu J, Li Y, Hopfinger AJ.
    J Chem Inf Comput Sci; 2004 Jan 25; 44(6):2083-98. PubMed ID: 15554679
    [Abstract] [Full Text] [Related]

  • 15. Delivery of peptides to the brain: emphasis on therapeutic development.
    Banks WA.
    Biopolymers; 2008 Jan 25; 90(5):589-94. PubMed ID: 18335425
    [Abstract] [Full Text] [Related]

  • 16. 3-D-QSAR and docking studies on the neuronal choline transporter.
    Geldenhuys WJ, Allen DD, Lockman PR.
    Bioorg Med Chem Lett; 2010 Aug 15; 20(16):4870-7. PubMed ID: 20637607
    [Abstract] [Full Text] [Related]

  • 17. [The blood-brain barrier and drug delivery in the central nervous system].
    Loch-Neckel G, Koepp J.
    Rev Neurol; 2010 Aug 15; 51(3):165-74. PubMed ID: 20645267
    [Abstract] [Full Text] [Related]

  • 18. Blood-brain barrier delivery.
    Pardridge WM.
    Drug Discov Today; 2007 Jan 15; 12(1-2):54-61. PubMed ID: 17198973
    [Abstract] [Full Text] [Related]

  • 19. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L.
    Drug Discov Today; 2008 Dec 15; 13(23-24):1099-106. PubMed ID: 18848640
    [Abstract] [Full Text] [Related]

  • 20. Putative proteins involved in manganese transport across the blood-brain barrier.
    Fitsanakis VA, Piccola G, Marreilha dos Santos AP, Aschner JL, Aschner M.
    Hum Exp Toxicol; 2007 Apr 15; 26(4):295-302. PubMed ID: 17615110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.